Metformin vs Yttrium Y 90 Ibritumomab Tiuxetan
Metformin vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview
This comparison examines the pharmacological differences between Metformin and Yttrium Y 90 Ibritumomab Tiuxetan.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pharmacokinetics
Half-life: Metformin — 4-9 hours.
Chemical Properties
Molecular Formula: Metformin — C4H11N5.
Molecular Weight: Metformin — 129.1640 g/mol.
Type: Metformin — Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.